Home
About
Overview
Sharing Data
ORCID
Help
History (29)
Luteolin
Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. A BALANCING VIEW: lifetime channeling of infliximab for crohn's disease.
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial.
Quiescent-interval single-shot unenhanced magnetic resonance angiography of peripheral vascular disease: Technical considerations and clinical feasibility.
Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes.
See All 29 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes.
Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes. Age (Dordr). 2008 Dec; 30(4):209-15.
View in:
PubMed
authors with profiles
George Perry